Nektar Therapeutics

NKTR | NASDAQ

Price Alert Chart Builder DCF Calculator

$67.42

+$0.58 (+0.87%)

Sep 22, 2026, 12:09 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-164.08M	-118.96M	-276.06M	-368.2M	-523.84M	-444.44M
Depreciation & Amortization	-4.49M	4.39M	7.82M	13.03M	14.15M	14.18M
Stock-Based Compensation	12.65M	21.61M	33.39M	57.32M	94.67M	94.26M
Other Working Capital	-36.39M	-6.36M	-22.39M	-15.72M	-23.27M	15.04M
Other Non-Cash Items	-15.58M	-76.51M	62.19M	-9.36M	17.41M	-14.35M
Deferred Income Tax	n/a	n/a	-140K	2.71M	8.02M	20.35M
Change in Working Capital	-37.02M	-6.24M	-19.8M	492K	-23.08M	16.71M
Operating Cash Flow	-208.51M	-175.71M	-192.61M	-304.01M	-412.66M	-313.29M
Capital Expenditures	-171K	-1.47M	-865K	-5.68M	-14.99M	-7.26M
Cash Acquisitions	-697K	65.39M	n/a	13.2M	-217.77M	-503.47M
Purchase of Investments	-285.01M	-261.71M	-511.7M	-467.91M	-960.69M	-987.53M
Sales Maturities Of Investments	284.68M	340.36M	650.88M	826.23M	1.18B	1.49B
Other Investing Acitivies	n/a	n/a	1.25M	n/a	217.77M	503.47M
Investing Cash Flow	-1.2M	142.57M	139.56M	365.84M	202.78M	496.21M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	-103.75M
Common Stock Repurchased	n/a	-3M	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	15M	n/a	750K	3M	n/a
Financial Cash Flow	180.57M	42.12M	30K	1.51M	36.24M	-80.35M
Net Cash Flow	-29.14M	8.98M	-52.95M	63.01M	-173.74M	102.59M
Free Cash Flow	-208.68M	-177.18M	-193.47M	-309.68M	-427.65M	-320.55M
Adj. Free Cash Flow	-221.33M	-198.79M	-226.86M	-367M	-522.32M	-414.81M
Maintenance CapEx	-171K	n/a	-865K	-5.68M	-14.99M	n/a
Growth CapEx	n/a	-1.47M	n/a	n/a	n/a	-7.26M
Owner Earnings	-208.68M	-175.71M	-193.47M	-309.68M	-427.65M	-313.29M